<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-BPMWN2LU</identifier><date>2022</date><creator>Boc, Nina</creator><creator>Skok, Tadeja</creator><relation>documents/doc/B/URN_NBN_SI_doc-BPMWN2LU_001.pdf</relation><relation>documents/doc/B/URN_NBN_SI_doc-BPMWN2LU_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 134-135</format><identifier identifier_type="COBISSID_HOST">102352387</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-BPMWN2LU</identifier><language>slv</language><publisher publisher_location="Ljubljana">Katedra za onkologijo</publisher><publisher publisher_location="Ljubljana">Onkološki inštitut</publisher><publisher publisher_location="Ljubljana">Sekcija za internistično onkologijo</publisher><source>Melanom in nemelanomski kožni raki</source><rights>InC</rights><subject language_type_id="slv">hipofizitis</subject><subject language_type_id="slv">melanom</subject><subject language_type_id="slv">rak kože</subject><title>Case report: hypofizitis in immunotherapy in metastatic melanoma (MR characteristics)</title><title>Elektronski vir</title><title>Prikaz primera: hipofizitis ob imunoterapiji metastatskega melanoma (MR značilnosti)</title></Record>